A detailed history of Mc Kinley Carter Wealth Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mc Kinley Carter Wealth Services, Inc. holds 21,232 shares of ABBV stock, worth $3.62 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
21,232
Previous 21,084 0.7%
Holding current value
$3.62 Million
Previous $3.62 Million 15.93%
% of portfolio
0.26%
Previous 0.23%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $24,248 - $29,500
148 Added 0.7%
21,232 $4.19 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $28,481 - $33,259
184 Added 0.88%
21,084 $3.62 Million
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $60,092 - $68,469
376 Added 1.83%
20,900 $3.81 Million
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $52,150 - $58,733
379 Added 1.88%
20,524 $3.18 Million
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $45,019 - $52,117
-337 Reduced 1.65%
20,145 $3 Million
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $41,873 - $52,108
-316 Reduced 1.52%
20,482 $2.76 Million
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $15,907 - $18,319
110 Added 0.53%
20,798 $3.31 Million
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $169,014 - $202,693
1,222 Added 6.28%
20,688 $3.35 Million
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $99,852 - $114,523
-744 Reduced 3.68%
19,466 $2.61 Million
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $22,156 - $28,168
161 Added 0.8%
20,210 $3.1 Million
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $144,518 - $179,306
1,095 Added 5.78%
20,049 $3.25 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $2,900 - $3,670
-27 Reduced 0.14%
18,954 $2.57 Million
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $59,052 - $67,032
555 Added 3.01%
18,981 $2.05 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $1,788 - $1,992
-17 Reduced 0.09%
18,426 $2.08 Million
Q1 2021

Apr 30, 2021

BUY
$102.3 - $112.62 $202,042 - $222,424
1,975 Added 11.99%
18,443 $2 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $67,450 - $91,065
838 Added 5.36%
16,468 $1.77 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $249,358 - $336,659
-3,098 Reduced 16.54%
15,630 $1.68 Million
Q3 2020

Oct 14, 2020

BUY
$85.91 - $100.83 $33,161 - $38,920
386 Added 2.1%
18,728 $1.64 Million
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $36,611 - $48,991
499 Added 2.8%
18,342 $1.8 Million
Q1 2020

May 01, 2020

BUY
$64.5 - $97.79 $93,589 - $141,893
1,451 Added 8.85%
17,843 $1.36 Million
Q4 2019

Jan 23, 2020

SELL
$72.13 - $90.25 $1,442 - $1,805
-20 Reduced 0.12%
16,392 $1.45 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $178,926 - $215,120
2,841 Added 20.93%
16,412 $1.24 Million
Q2 2019

Aug 02, 2019

BUY
$65.7 - $83.98 $20,892 - $26,705
318 Added 2.4%
13,571 $987,000
Q1 2019

May 08, 2019

BUY
$77.14 - $90.79 $111,235 - $130,919
1,442 Added 12.21%
13,253 $1.07 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $180,767 - $222,935
2,322 Added 24.47%
11,811 $1.09 Million
Q3 2018

Nov 06, 2018

BUY
$88.91 - $98.84 $13,069 - $14,529
147 Added 1.57%
9,489 $897,000
Q2 2018

Dec 07, 2018

BUY
$89.78 - $106.23 $77,390 - $91,570
862 Added 10.17%
9,342 $866,000
Q1 2018

May 17, 2018

BUY
$92.01 - $123.21 $150,988 - $202,187
1,641 Added 23.99%
8,480 $803,000
Q4 2017

Jan 31, 2018

SELL
$89.56 - $98.21 $895 - $982
-10 Reduced 0.15%
6,839 $661,000
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $169,875 - $216,983
2,432 Added 55.06%
6,849 $609,000
Q2 2017

Aug 08, 2017

BUY
N/A
4,417
4,417 $320,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mc Kinley Carter Wealth Services, Inc. Portfolio

Follow Mc Kinley Carter Wealth Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Kinley Carter Wealth Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Kinley Carter Wealth Services, Inc. with notifications on news.